Next, nanorobots with different aptamer locks were loaded with fluorescently labeled antibodies against human leukocyte antigen (HLA)–A/B/C and mixed with various types of cancer cells expressing human HLA–A/B/C, as well as expressing various protein targets for aptamers in the lock. This evidence concerns the gene HLA-A and cancer.